List of insiders holdings for LAVA Therapeutics NV:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 2025-02-06 19:29:39 | 3,407,157 1,180,680 | 4,587,837 | Form 3 |
| HURLY STEPHEN A Chief Executive Officer | 2025-02-18 20:15:04 | 335,100 0 | 335,100 | Form 4 |
| Morris Charles Q Chief Medical Officer | 2025-02-18 20:15:09 | 130,850 0 | 130,850 | Form 4 |
| Powell Fred M Chief Financial Officer | 2025-02-18 20:15:11 | 124,700 0 | 124,700 | Form 4 |
| Oliger Christy J. Director | 2025-02-18 20:15:07 | 33,390 0 | 33,390 | Form 4 |
| Dhingra Kapil Director | 2025-02-18 20:15:13 | 33,390 0 | 33,390 | Form 4 |
| Backstrom Jay T. Director | 2025-02-18 20:15:15 | 33,390 0 | 33,390 | Form 4 |
| Kiener Peter A Director | 2025-02-18 20:15:17 | 33,390 0 | 33,390 | Form 4 |
| Noble James Director | 2025-02-18 20:15:20 | 33,390 0 | 33,390 | Form 4 |
| Wadlinger Mary E. Director | 2025-02-18 20:15:22 | 33,390 0 | 33,390 | Form 4 |
| WILSON KAREN J Director | 2025-02-18 20:15:24 | 33,390 0 | 33,390 | Form 4 |